286 related articles for article (PubMed ID: 15254018)
1. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
[TBL] [Abstract][Full Text] [Related]
2. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
[TBL] [Abstract][Full Text] [Related]
3. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
[TBL] [Abstract][Full Text] [Related]
4. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.
Jia W; Deng Z; Zhu J; Fu W; Zhu S; Zhang LY; Hu J; Wang F; Xia H; Liu GC; He J
Cancer Invest; 2017 Nov; 35(10):633-638. PubMed ID: 29243987
[TBL] [Abstract][Full Text] [Related]
5. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
[TBL] [Abstract][Full Text] [Related]
6. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
[TBL] [Abstract][Full Text] [Related]
8. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the HACE1 gene is frequently detected in hepatocellular carcinoma.
Sakata M; Yokomizo K; Kitamura Y; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
Hepatogastroenterology; 2013 Jun; 60(124):781-3. PubMed ID: 23732777
[TBL] [Abstract][Full Text] [Related]
10. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
Finver SN; Martiniere C; Kagan J; Cavenee W; Croce CM
Oncogene Res; 1989; 5(2):143-8. PubMed ID: 2558334
[TBL] [Abstract][Full Text] [Related]
11. The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour.
Vernon EG; Malik K; Reynolds P; Powlesland R; Dallosso AR; Jackson S; Henthorn K; Green ED; Brown KW
Oncogene; 2003 Mar; 22(9):1371-80. PubMed ID: 12618763
[TBL] [Abstract][Full Text] [Related]
12. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus.
Boehm T; Lavenir I; Forster A; Wadey RB; Cowell JK; Harbott J; Lampert F; Waters J; Sherrington P; Couillin P
Oncogene; 1988 Dec; 3(6):691-5. PubMed ID: 2577871
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
14. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.
Drake KM; Ruteshouser EC; Natrajan R; Harbor P; Wegert J; Gessler M; Pritchard-Jones K; Grundy P; Dome J; Huff V; Jones C; Aldred MA
Clin Cancer Res; 2009 Oct; 15(19):5985-92. PubMed ID: 19789318
[TBL] [Abstract][Full Text] [Related]
17. Unbalanced translocation of chromosome 3p in Wilms' tumor.
Walton JM; Lee CL; Mikhail E; Welch JP; Gillis DA
J Pediatr Surg; 1992 Oct; 27(10):1311-4. PubMed ID: 1328583
[TBL] [Abstract][Full Text] [Related]
18. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
[TBL] [Abstract][Full Text] [Related]
20. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
